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The diagnosis of schizophrenia is thought to embrace several distinct subgroups. The manifold entities in a single
clinical patient group increase the variance of biological
measures, deflate the group-level estimates of causal factors, and mask the presence of treatment effects. However,
reliable neurobiological boundaries to differentiate these
subgroups remain elusive. Since cortical thinning is a
well-established feature in schizophrenia, we investigated if individuals (patients and healthy controls) with
similar patterns of regional cortical thickness form naturally occurring morphological subtypes. K-means algorithm clustering was applied to regional cortical thickness
values obtained from 256 structural MRI scans (179 patients with schizophrenia and 77 healthy controls [HCs]).
GAP statistics revealed three clusters with distinct regional thickness patterns. The specific patterns of cortical
thinning, clinical characteristics, and cognitive function
of each clustered subgroup were assessed. The three clusters based on thickness patterns comprised of a morphologically impoverished subgroup (25% patients, 1% HCs),
an intermediate subgroup (47% patients, 46% HCs), and
an intact subgroup (28% patients, 53% HCs). The differences of clinical features among three clusters pertained to
age-of-onset, N-back performance, duration exposure to
treatment, total burden of positive symptoms, and severity
of delusions. Particularly, the morphologically impoverished group had deficits in N-back performance and less
severe positive symptom burden. The data-driven neuroimaging approach illustrates the occurrence of morphologically separable subgroups in schizophrenia, with distinct
clinical characteristics. We infer that the anatomical

heterogeneity of schizophrenia arises from both pathological deviance and physiological variance. We advocate
using MRI-guided stratification for clinical trials as well
as case–control investigations in schizophrenia.
Key words: heterogeneity of schizophrenia/cortical
thickness/clustering analysis
Introduction
Schizophrenia is a complex and persistent mental disorder with a variable course, often associated with
dramatic deterioration in functioning. Unfortunately, despite decades of clinical research, only one in six patients
with schizophrenia achieve rates of clinical and community functioning on par with their premorbid levels.1
This variability in treatment response has led a number
of studies to posit that schizophrenia, rather than a
single disorder, may represent a group of distinct entities
with overlapping clinical phenotypes.2–4 The idea of heterogeneity in schizophrenia is not new, with Kraepelin
admitting that dementia praecox is “the expression of a
single morbid process, though outwardly they often diverge very far from one another.” 5 However, despite continued effort, focus on subclassifying patients based on
strictly clinical presentation has shown little prognostic
value. Advances in Magnetic Resonance Imaging (MRI)
technology have provided researchers with a widely available and biologically safe method to investigate the posited presence of neurobiologically derived subgroups in
patient populations.
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Methods
Participants
Patients (n = 179) with a diagnosis of schizophrenia
(using the Structured Clinical Interview for DSM-IVpatient version [SCID-P]14) were recruited from the inpatient and outpatient units at Second Xiangya Hospital of
Central South University, Changsha, China from 2009
to 2017. All patients: (1) met the DSM-IV diagnostic
criteria for schizophrenia; (2) were 12–45 years of age;
624

(3) right-handed; and (4) had 9 or more years of formal
schooling. The exclusion criteria included: (1) diagnosis
of a substance-related disorders, neurological disorder,
or a serious physical illness; (2) any contraindication for
MRI; and (3) previous electroconvulsive therapy.
In addition to our patient population, we recruited
n = 77 healthy controls (HCs) from a community sample
in Changsha city. The inclusion and exclusion criteria were
the same as those of the patient group, with the exception
that controls were (1) not diagnosed with any mental illness according to the DSM-IV when interviewed using
the SCID nonpatient version (2) did not have first-degree relatives with a psychotic illness. All participants
gave their written informed consent to participate in our
study after a detailed description of the risks and benefits. The study was approved by the ethics committee of
the Second Xiangya Hospital, Central South University.
Clinical Assessment
Diagnoses were made by qualified psychiatrists according
to DSM-IV criteria. On the same day as the MRI session,
the severity of symptoms was evaluated through the Scale
for The Assessment of Positive Symptoms (SAPS),15
the Scale for The Assessment of Negative Symptoms
(SANS),15 and the Schizophrenia Suicide Risk Scale
(SSRS).16 The duration of illness, antipsychotic load
(converted into chlorpromazine equivalent per day), and
duration of psychotic medication were recorded.
MRI Acquisition
MRI scanning was conducted on a Philips Gyroscan
Achieva 3.0 Tesla MRI scanner at the Institute of Mental
Health, Second Xiangya Hospital. High-resolution
T1-weighted images were also acquired with a three-dimensional spoiled gradient echo (SPGR) pulse sequence
from the sagittal plane, scanning parameter: TR = 7.5 ms,
TE = 3.7 ms, FA = 8°, 180 slices, matrix = 256 × 200, the
field of view (FOV) = 240 × 240 mm2, and slices were
contiguous with a slice thickness of 1 mm. Importantly,
during the T1-weighted image acquisition, participants
were asked to remain still, and if any motion-related artifacts were detected, the scans were repeated.
Cognitive Function Assessment
On the same day of the MRI acquisition, Verbal Fluency,
N-back task and Contour Integration Test were administered. Verbal Fluency was tested by asking participants
to report as many animals as possible within 60 s. The
N-back task was widely used in previous studies of our
research group.17–19 All participants performed a parametric n-back task on Nordic Neurolab’s fMRI hardware system for 8 minutes and 16 seconds. All stimuli
were sequences of white capital letters on a black background, presented centrally (500 ms duration, 1500 ms
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In a large-scale multisite study, Clementz et al used multivariate taxometric analyses of MRI to identify specific
biotypes of psychosis and found three neurobiologically
distinct psychosis biotypes that did not conform to
typical diagnostic boundaries between schizophrenia,
schizoaffective disorder, and bipolar disorder.6 This
suggests that biomarker-based stratification could necessitate a reconceptualization of traditional diagnostic
classifications.1–3
Recent imaging studies have revealed that schizophrenia patients show regional cortical thinning in
several brain areas,4 and this has become an area of
interest to assess the potential for neurobiological
heterogeneity in schizophrenia.5–8 Although this is a
promising line of inquiry, identifying the appropriate
number of subtypes has proven difficult, with ranges
from 3 to 6 groups being identified in previous anatomical MRI studies.5–8 Furthermore, the degree to which
ethnicity will affect assessments of neurobiological subgroups should be assessed as many ethnic differences
exist in incidence rates, illness severity, and degree of
functional recovery.9
In most case–control studies, there is an absence of clear
biological demarcation between patients and controls due
to small effect sizes or a high degree of variance among
patients. Nevertheless, most clustering studies seek biological boundaries only among patients, assuming that
a natural distinction exists between patients and healthy
controls.10,11 Thus, the effect of variation in the healthy
brain (i.e., normative modeling) has not been utilized
fully when studying the heterogeneity of schizophrenia.12
Healthy controls do not form a neurobiologically homogeneous group that deviates from the patient subgroups,
as within-group heterogeneity of features such as cortical
thickness in healthy controls is substantial.13
Using a data set-based clustering approach for all participants (schizophrenia patients and healthy controls),
we aim to resolve the inconsistency around the identity
of biologically heterogeneous subtypes of schizophrenia.
After clustering, the characteristics of each cluster will be
revealed through clinical information such as diagnosis
and symptoms and cognitive tasks. We sought to use a
data-driven approach based on neurobiological traits to
explore the distinct patterns of morphological variation
and the nature of schizophrenia subtypes.

Morphological Profiling of Schizophrenia

Preprocessing of MRI Data
A surface-based approach using Free-Surfer (http://
surfer.nmr.harvard.edu, version 5.3.0) was used to calculate the cortical thickness in the whole brain. Following
skull-stripping and intensity correction, the gray–white
matter boundary for each cortical hemisphere was determined by tissue intensity and neighborhood constraints.
The resulting surface boundary was tessellated to generate multiple vertices across the whole brain before
inflating. Using a deformable surface algorithm guided by
the gray–CSF intensity gradient, the resulting gray–white
interface was expanded to create the pial surface. The inflated surface was then morphed into a sphere followed

by registration to an average spherical surface for optimal sulcogyral alignment. After the above procedures,
Desikan–Kiliany Atlas (68 regions) was used to extract
cortical thickness of each region using the FreeSurfer
software.23 Topological defects were corrected manually
by two members of the research staff.
Statistical Analysis
Using cortical thickness of 68 regions, we used the
K-means clustering method and GAP statistics to identify clusters of participants who shared similar patterns
of cortical thickness. K-means clustering was applied to
all participants, including HCs. We set K number from 1
to 6 and GAP statistics to estimate the optimal number
of clusters in our data. Then we chose the smallest K
number that conformed to Gap(k) ≥ Gap(k + 1) − sk+1 as
the solution of cluster analysis based on the 1-standarderror method suggested by Tibshirani.24 Based on the
coordinates of each cluster center, we computed the distance from each individual to each of the three centers.
One-way ANOVA (SPSS 20.0) was used to compare
morphological, clinicodemographic, and cognitive indices, with Bonferroni correction to address inflated type
1 error. For data with non-normal distribution (e.g., percentile data on the accuracy of N-back), we used nonparametric Kruskal–Wallis test for statistical analysis. We
also investigated the correlation between distance from
each cluster center and clinical and cognitive scores. At
last, a multivariate generalized linear model with the subgroup based on clusters as the fixed factor was used to
test the effect size of all factors including morphological
data and phenotypic characteristics.
Results
Demographic and Clinical Characteristics of All
Participants
A total of 256 participants (179 SCH, 77 HC) were recruited for the study. The demographic and clinical variables of participants are presented in Table 1. Significant
differences were found in gender (P = .014), InformationWAIS (P < .00001), Digit symbol-WAIS (P < .00001),
and education (P < .00001), but not in age (P = .288)
between the two diagnostic groups. As expected patients
showed significant cognitive impairment compared with
HC in three cognitive tasks, including contour task (visual
integration), verbal fluency task (language fluency), and
N-back task (working memory) (Table 1).
K-Means Clustering and GAP Statistics
We explored the possibility of the existence of one to six
clusters and identified the ideal cluster solution based
on GAP statistics to be 3 (Figure 1A). According to
the proportion of patients compared with controls in
625
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inter-stimulus interval) in a pseudo-random order. The
task performance, as represented by the reaction time
[RT] and accuracy [AC], of each participant was recorded
electronically.
The Contour Integration Test is designed to measure
perceptual organization.20–22 This test is typically a
task to recognize a closed contour circle made up of
noncontiguous elements, embedded within a display of
randomly oriented elements in a card. Further details of
the test administration are provided in the Supplementary
Figure 1.
Principal component analysis (PCA) was applied
across the whole patient group to reduce multiple comparisons by extracting the components that accounted
for the majority of variance for each cognitive task. For
N-back target accuracy of 0 back, 2 back, for the whole
test and N-back nontarget accuracy (error rate of whole
test) were entered into PCA; for contour task, the number
of total correct, incorrect, and failure for random testing,
total correct, incorrect, and failure for standard testing,
were entered into PCA; for verbal fluency task, number
of correct responses, wrong responses, and repetitions
were entered into PCA. We extracted one principal component for the N-back scores (accounted for 59% of variance); two components were extracted for the contour
task scores (component 1 accounted for 50% of variance
and component 2 accounted for 24% of variance) with
four items in component 1(omitted score) and three items
in component 2 (correct committed score). Two components were extracted for the verbal fluency scores (component 1 accounted for 43% of variance and component
2 accounted for 33% of variance) with two items in component 1(correct response score) and one item in component 2 (noncategory responses score). We used PCA
as the original variables within each test are correlated
highly with each other and only the latent components
of overall test performance were needed for our purpose
of correlating with external variable (in this case cluster
membership). Furthermore, there are no universally
agreed single composite indices for reporting n-back and
contour integration test performance.

Y. Pan et al

Table 1. Participant Demographic Information, Symptom, and
Cognitive Scores
SCH
HCs
P value
(mean ± SD) (mean ± SD) (uncorrected)
N
Age [range]

77
24.52 ± 5.63
[18–42]
39/38

11.58 ± 2.42 14.05 ± 2.25
15.81 ± 5.30 21.16 ± 4.53
62.30 ± 15.45 89.46 ± 14.53
198 ± 445
—

.288
.014*
<.00001**
<.00001**
<.00001**
—

134 ± 117

—

—

25.42 ± 32.66

—

—

21.59 ± 5.48
20.60 ± 15.63
33.54 ± 26.52

—
—
—

—
—
—

0.78 ± 0.25

0.92 ± 0.15

.000007**

0.83 ± 0.27

0.94 ± 0.16

.000296**

0.52 ± 0.25

0.76 ± 0.19

0.86 ± 0.19

0.78 ± 0.22

43.75 ± 4.16

46.07 ± 3.69

3.32 ± 6.31

2.38 ± 3.90

70.77 ± 8.81

77.54 ± 7.74

7.15 ± 10.84

<.00001**
.001*
.001655*
.2486
.00002**

6.49 ± 6.52

.62772

13.98 ± 5.06

20.37 ± 5.46

<.00001**

0.17 ± 0.40

0.10 ± 0.31

.373

0.68 ± 0.94

0.81 ± 0.98

.397

Note: After Bonferroni correction, the significant difference level
was 4.16e-4.
*P < .05; **P < 4.16e-4.

each cluster, we deduced that cluster 1 (98% are schizophrenia) was “schizophrenia-like,” cluster 2 (67% are
schizophrenia) was “HCs-like,” and cluster 3 (59% are
schizophrenia) was intermediate (Figure 1B). When the
individual features (regional thickness) were examined
in patients compared with all HCs, patients had cortical
thinning patterns that differed according to their cluster
membership. Schizophrenia patients in cluster 2 appeared
to be “morphologically intact,” with a pattern of cortical
thickness similar to HCs; schizophrenia patients in cluster
1, “morphologically impoverished,” appeared to have a
pattern of widespread cortical thinning. Schizophrenia
626

Characteristics of Each Cluster
There was no significant overall effect of subgrouping
on gender, education, and cognition (Tables 2 and 3).
However, there was a significant difference in age between
clusters (P = .000) (Table 2). Post hoc analysis (performed
for ANOVA P < .15) showed that the participants in
cluster 2 were younger compared with those in clusters 1
and 3 (P = .000 and .043, respectively). Besides, Kruskal–
Wallis analysis showed that the participants in cluster 2
had greater performance of N-back (P = .04).
In schizophrenia patients, there were no significant
effects of cluster on SANS total and SRSS total (Table
2). However, there were significant effects of cluster on
duration of medication exposure (DoM) and delusion
(P = .041 and .049, respectively) (Table 2). Post hoc
analysis showed that patients in cluster 1 (the “morphologically impoverished” group) had lower score in digit
symbol-WAIS (P = .046), longer duration of illness (DoI),
and DoM (P = .044 and .023, respectively), but lower
scores in SAPS total and delusion (P = .033 and .016, respectively) (Table 2) compared with those in cluster 2 (the
“morphologically intact” group). In addition, patients in
cluster 3 (the “intermediate” group) had older onset age
compared with those in cluster 2 (the “morphologically
intact” group).
The demographic, cognitive, and clinical characteristics were summarized in Figure 2 (also see Supplementary
Table 2 for cluster differences among the healthy controls). And the differences among the 3 clusters were
observed in Age, N-back, DoI, DoM, Onset age, SAPS
total, and Delusions. We also collected 5-year outcome
data on positive symptom relapses and education/employment status using telephone interview and hospital
chart review for 59 of 179 patients in this study. These
results are presented in the Supplementary Figure 4.
Distance From Individuals to Cluster Central Point
Squared Euclidean distance was used to express distance from individual to cluster central point. According
to the solution of K-means clustering, there were three
central points (CP) corresponding to three clusters
(Supplementary Figure 5). Significant differences were
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Gender (female/
male)
Education
Information-WAIS
Digit symbol-WAIS
Duration_of_
Medicine (Days)
Dosage_of_Medicine
(CPZ equivalent)
Duration_
of_illness (months)
Onset_age
SAPS scores
SANS scores
Cognitive task
 N-back
Textdisplay2_ACC
 N-back
Textdisplay1_ACC
 N-back Target_
ACC
 N-back
Nontarget_ACC
 Contour Random
total correct
 Contour Random
total wrong
 Contour Standard
total correct
 Contour Standard
total wrong
 Verbal fluency
correct
 Verbal fluency
wrong
 Verbal fluency
repeat

179
23.63 ± 5.77
[13–44]
61/117

patients in cluster 3, “intermediate,” showed regional cortical thinning compared with HCs (Figure 1C). The central point (CP) of each cluster supported above different
patterns of clusters (Supplementary Figure 5).
Among the three subgroups clusters, the effect size
of differences (partial eta squared) in thickness for left
parstriangularis area, left temporal pole, right fusiform
area, bilateral middle temporal cortex, and bilateral superior temporal cortex was >0.5 (Supplementary Table 3),
indicating a critical role for these regions in the observed
heterogeneity of schizophrenia.

Morphological Profiling of Schizophrenia

observed in distance to the CP of each cluster. Distance
from schizophrenia patients to CP1 was significantly
(P = .03) lower than the distance from HCs to CP1; distance from schizophrenia patients to CP2 and CP3 was
significantly higher than the distance from HCs to CP2
and CP3 (Figure 3A). Thus, CP1 subgroup more closely
reflected the clinical description of schizophrenia while
CP2 and CP3 were closer to HCs in their profile. Besides,
the correlation between the characteristics of clusters and

distance to CP of all samples is presented in Figure 3B.
See Supplementary Figure 2 for the stability of cluster
membership to sample size balance, age, and sex.
Discussion
To the best of our knowledge, this is the first study using
a data-driven approach to reveal subgroups in relatively
early stage of schizophrenia (77.6% patients having
627
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Figure 1. (A) Gap statistic to measure the number of optimum cluster in the data set using K-means clustering. The optimal solution
for the morphological data from both patients and controls is the presence of three clusters. (B) The composition of each cluster, with
98%, 59%, and 67% of each cluster being comprised of patients, is shown. (C) Different patterns of cortical thinning in three clusters
of patients (Cl, C2, and C3). The age- and gender-adjusted differences between patients in each cluster and the total sample of HCs are
shown by the coloured cells (with red indicating Bonferroni-adjusted P < .05). The name of the corresponding regions from the Desikan–
KIlliany atlas is shown in Supplementary Table 3.

Y. Pan et al

Table 2. Characteristics of Each Cluster
Cluster1

Cluster 2

Cluster 3

46(1/45)

85(35/50)

125(41/84)

Mean

SD

Mean

SD

Mean

SD

Age
Gender
Education
Information-WAIS
Digit symbol-WAIS
DoI (months)
DoM (days)
Onset_age
SAPS total
Hallucinations
Delusions
Bizarre Behavior
Positive FTD
SANS total
Affective Flattening
Alogia
Avolition-Apathy
Anhedonia-Asociality
Attention
SSRS total

24.02
1.39
12.13
16.40
64.50
32.6
328
21.6
17.69
1.24
1.73
0.98
0.73
29.58
1.29
1.09
1.62
1.82
1.16
13.58

6.11
0.49
2.71
6.17
12.74
40.1
665
5.2
15.54
1.65
1.59
1.35
1.13
17.78
1.41
1.35
1.54
1.54
1.52
9.54

21.95
1.35
12.34
18.00
72.08
18.6
98
20.3
24.56
1.22
2.53
1.10
0.91
31.65
1.33
1.43
1.90
2.10
1.37
15.28

4.30
0.48
2.49
5.88
19.32
25.4
194
5.1
16.96
1.54
1.67
1.26
1.28
24.18
1.36
1.32
1.46
1.56
1.30
9.65

25.13
1.41
12.33
17.34
71.10
25.5
186
22.4
19.84
1.34
2.02
1.17
0.82
36.76
1.75
1.52
2.00
2.28
1.50
13.53

6.03
0.49
2.71
5.21
21.60
31.5
389
5.7
14.57
1.62
1.55
1.31
1.17
27.04
1.45
1.45
1.58
1.47
1.44
7.56

F/χ 2 value

P value
(uncorrected)

8.31
0.73
0.12
1.069
2.252
2.186
3.263
2.242
2.501
0.108
3.069
0.306
0.281
1.249
2.171
1.462
0.888
1.380
0.855
0.633

.00032*
.695
.889
.345
.108
.115
.041*
.109
.085
.898
.049*
.737
.755
.289
.117
.235
.413
.254
.427
.532

Post Hoc
1>2*, 2<3**
—
—
1<2*
1>2*
1>2*
2<3*
1<2*
—
1<2*
—
—
—
—
—
—
—
—
—

Note: Clinical ratings were administered only to participants with schizophrenia diagnose.
SCH, schizophrenia patients; HCs, healthy controls; DoI, duration of illness; DoM, duration of medication; FTD, formal thought disorder.
After Bonferroni correction, the significant difference level was 2.63e-4.
*P < .05; **P < 2.63e-4.
Table 3. Cognitive Comparison Between Clusters
Cluster1

N-back component
Contour task
Component 1
Component 2
Verbal Fluency
Component 1
Component 2

Cluster 2

Cluster 3
SD

Mean

SD

Kruskal–Wallis
χ 2 value

P value
(uncorrected)

0.21

0.86

−0.07

1.13

4.01

.14

1<2*

1.08
0.92

0.07
−0.01

1.03
0.89

0.114
−0.09

0.91
1.11

5.69
2.46

.58
.29

—
—

0.97
1.07

−0.04
0.33

0.98
1.17

−0.03
−0.14

1.04
0.81

0.28
2.03

.87
.36

—
—

Mean

SD

−0.11

0.84

−0.25
0.15
0.06
−0.04

Mean

Post Hoc

Note: After Bonferroni correction, the significant difference level was 0.005.
*P < .05; **P < .005.

<3 years of illness) based on cortical thickness. Applying
data-driven clustering to a combined sample of HCs and
patients, we identified three subgroups of schizophrenia
with distinct patterns of cortical thinning. One subgroup
was homogeneously comprised of patients (except for
one HC) with widespread reduction in regional cortical
thickness. A substantial proportion (33% and 41%) of the
other two subgroups comprised of HCs, with patients in
cluster 2 exhibiting a highly preserved thickness profile,
whereas cluster 3 being intermediate (as shown in Figure
1). This result suggests that anatomical heterogeneity is
628

not solely an inherent disease feature, but rather representative of variation that can exist in HCs as well. In fact,
only 25% of all patients were from the morphologically
impoverished group, whereas the rest had cortical thickness features that were shared with healthy controls.
We observe that patients in the morphologically
intact subgroup (cluster 2) are more symptomatic
(SAPS total, delusions) with a shorter duration of
illness and intact cognition (n-back) than the impoverished group (cluster 1), though there were no differences in sex, negative symptom burden, verbal
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N(HCs/SCH)

Morphological Profiling of Schizophrenia

Figure 3. Distance from individuals to cluster central point. (A) presents the difference of distance between SCH (blue) and HCs (red).
(B) presents correlations between characteristics of clusters and distance to CP. For diagnosis, 1 = SCH, 2 = HCs. Note: Clinical ratings
were available for patients only. After Bonfferoni correction, the significant difference level was P < .0017. * represent P < .05; ** means
P < .0017.

629
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Figure 2. The demographic, cognitive, and clinical characteristics of the three morphological subgroups. (A) Post hoc comparison
between clusters in phenotypes. * represents uncorrected P < .05; (B) The Y-axis represents the Z-scores of each factor (N-back-axis was
the results of PCA). Cluster 1, “morphologically impoverished subgroup,” exhibited older age, lower digit symbol score, worse working
memory, and longer DoT and DoM; Cluster 2, “morphologically intact subgroup,” exhibited younger age, higher delusion, and severity
of positive symptoms; Cluster 3, “intermediate subgroup,” exhibited older age and onset age.

Y. Pan et al
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a relationship was not seen in the morphologically intact cluster 2, wherein the duration of exposure to antipsychotics was the most influential factor in deviation
from the centroid. Furthermore, the cluster solution was
stable even when adolescent subjects were excluded from
the sample (Supplementary Figure 3 and Supplementary
Table 1), indicating that the subgroups may be stable irrespective of the age range of the sample studied. The most
morphologically impoverished cluster 1 had highest duration of illness as well as medication exposure, but these
factors did not relate to the strength of an individual’s
cluster membership. This is consistent with the suspected “detrimental” effects of antipsychotics on brain
morphology,32 as noted in other clustering studies4,8 but
suggests that the medication-related variations are likely
to be in line with the variability seen in healthy controls.
Limitations
The current study contained several limitations that
should be considered. First, despite being agnostic with
respect to the diagnostic differences in cortical thickness, our clinical recruitment was based on established
clinical criteria for schizophrenia and did not include a
broader spectrum of psychosis. A large number of prior
observations have indicated that the structural pattern in
other psychotic disorders is not qualitatively different but
appears to be intermediate between schizophrenia and
healthy controls. Secondly, we lacked longitudinal data
to confirm the stability of observed clusters. Mechanistic
heterogeneity at the individual level may be present across
time (ie, different pathways acting at different time points,
producing the same phenotype for the individual).33 Given
the cross-sectional nature of most clustering studies to
date, the question of stability in cluster solutions remains
unknown to date. Third, we were not able to untangle the
association between antipsychotic exposure, age of onset,
and illness duration, as we lacked a nonmedicated sample
of patients. Although antipsychotic confounds are absent
in untreated samples, cognitive and clinical symptoms are
often unstable in acute stages of psychosis. Nevertheless,
caution must be exercised in interpreting medication effects reported here.
We conclude that cortical thickness patterns in a large
number of patients with schizophrenia (~75% in this
sample) are not deviant but show variations parallel
to healthy controls. This raises the interesting question
of partitioning the anatomical heterogeneity in schizophrenia to a component of likely pathological perturbation and a component resulting from normative
variations in healthy morphology. Given the challenges
in reproducing case–control differences, a stratified approach towards identifying distinct sources of variation
may be critical in our pursuit of the etiological heterogeneity of schizophrenia. Furthermore, interventional
studies that aim to demonstrate structural changes in
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fluency, and contour recognition. The subgroup with
maximal thickness reduction (cluster 1) had the most
pronounced cognitive deficits while the subgroup with
the least thickness changes (cluster 2) had higher positive symptom burden (especially delusions) and somewhat higher frequency of positive symptom relapses.
While initially counterintuitive, these results are indeed
consistent with Crow’s original dichotomy of a morphologically preserved type-1 schizophrenia with more
positive symptom burden and a more chronic, cognitively impaired and structurally altered type-2 schizophrenia with less positive symptoms.25 Furthermore,
our results support various studies that reject the notion that positive symptoms per se are neurotoxic (ie,
presence of delusions/hallucinations will adversely affect the brain anatomy).26,27 Several recent longitudinal
studies support the possibility of a cortical reorganization or repair process that ameliorates morphological deficits occurring after the onset of psychosis (see
ref. 28 for a review). Our observation suggests that it is
likely that such reorganization processes, if present, are
more likely in patients with higher degree of positive
symptom burden, but lower degree of cognitive impairment. The preservation of cognitive function in the
morphologically intact subgroup is consistent with the
well-replicated association between cognitive impairment and morphological deficits in schizophrenia.29,30
Although we report three morphologically distinguishable subgroups of schizophrenia based on normative modeling that exploits the variations in healthy
brain structure, it is important to note that this does not
imply that only three morphological subtypes of schizophrenia exist. Prior studies have identified two11 to six
subgroups.8 The exact numbers reported vary according
to sampling and methodological differences (termed as
apparent heterogeneity by Schnack12). We recruited medicated patients in a relatively early stage of schizophrenia,
all of same ethnicity (Han Chinese), limiting generalizability to more chronic samples from other parts of the
world. We also chose to use k-means clustering instead of
fuzzy clustering, so cluster membership (and clinical distinctions) of individual subjects can be meaningfully interpreted, though the discrete classes thus generated may
have less information than fuzzy solutions. We also did
not seek a specific number of clusters, and remained agnostic to the number of subgroups. The 3-cluster solution
was found optimal based on the data-based gap statistic,
which outperforms other cluster solution methods,24 and
has the specific advantage of working in combination
with an adaptive version of K-means clustering in finding
elongated clusters.24,31
When studying the effect of clinical phenotype on the
cluster membership (distance from cluster centroids),
we note that age has a distinct gradient in the most impoverished and intermediate subgroups, with older age
indicating more pronounced cortical thinning. Such
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schizophrenia are best designed with the consideration
of the relative prevalence of subgroups of patients with
normal variations as opposed to disease-specific perturbations in morphology.
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